Janus International Group, Inc.
Janus International Group, Inc. (JBI) Financial Performance & Income Statement Overview
Analyze Janus International Group, Inc. (JBI) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Janus International Group, Inc. (JBI) Income Statement & Financial Overview
Analyze Janus International Group, Inc.’s JBI earnings with segmented quarterly and yearly financial statement figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $210.50M | $230.80M | $230.10M | $248.40M |
Cost of Revenue | $128.60M | $143.60M | $138.90M | $148.70M |
Gross Profit | $81.90M | $87.20M | $91.20M | $99.70M |
Gross Profit Ratio | $0.39 | $0.38 | $0.40 | $0.40 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $56.60M | $65.20M | $61.70M | $57.40M |
Operating Expenses | $56.60M | $74.40M | $64.50M | $47.80M |
Total Costs & Expenses | $185.20M | $218.70M | $203.40M | $196.50M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $10.20M | $10.70M | $11.60M | $13.00M |
Depreciation & Amortization | $11.20M | $11.40M | $11.20M | $11.20M |
EBITDA | $36.80M | $29.00M | $37.90M | $63.90M |
EBITDA Ratio | $0.17 | $0.13 | $0.16 | $0.26 |
Operating Income | $25.30M | $12.80M | $26.70M | $51.90M |
Operating Income Ratio | $0.12 | $0.06 | $0.12 | $0.21 |
Other Income/Expenses (Net) | -$9.90M | -$5.90M | -$11.60M | -$14.50M |
Income Before Tax | $15.40M | $6.90M | $15.10M | $37.10M |
Income Before Tax Ratio | $0.07 | $0.03 | $0.07 | $0.15 |
Income Tax Expense | $4.60M | $6.60M | $3.30M | $9.50M |
Net Income | $10.80M | $300000.00 | $11.80M | $27.60M |
Net Income Ratio | $0.05 | $0.001 | $0.05 | $0.11 |
EPS | $0.08 | $0.002 | $0.08 | $0.19 |
Diluted EPS | $0.08 | $0.002 | $0.08 | $0.19 |
Weighted Avg Shares Outstanding | $140.05M | $140.90M | $143.67M | $145.86M |
Weighted Avg Shares Outstanding (Diluted) | $140.27M | $141.43M | $144.28M | $146.44M |
Financial performance has remained strong, with revenue growing from $248.40M in Q2 2024 to $210.50M in Q1 2025. Gross profit continued to perform well, with margins at 39% in the latest quarter. Operating income reached $25.30M in Q1 2025, holding a steady 12% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $36.80M. Net income rose to $10.80M, keeping EPS at $0.08. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan